• / Free eNewsletters & Magazine
  • / My Account
Home>Funds>T. Rowe Price Health Sciences

T. Rowe Price Health Sciences

  1. All
  2. Morningstar Articles
  3. Videos
  4. Investing
  5. Research
  1. Favorite Long-Term Retirement Holdings

    Readers reveal what they keep in their third buckets, including conservatively run funds, dividend-paying stocks, and real estate.

  2. Behind T. Rowe Price Capital Appreciation's Gold Rating

    The following is an excerpt from Morningstar's Premium Analyst Report for T. Rowe Price Capital Appreciation PRWCX, a moderate allocation fund that receives a Gold Fund Analyst Rating from Morningstar analysts. Morningstar.com Premium Members can  click here to see the full Analyst Report. Not a ...

  3. What Investors Were Researching in September

    International opportunities, income, and M&A activity were on investors' minds in September.

  4. Caution: Tax Bills Ahead

    A survey of this season's capital gains distribution estimates.

  5. Caution: Tax Bills Ahead

    A survey of this season's capital gains distribution estimates.

  6. Another T. Rowe Price Manager Departs

    Rob Bartolo plans to relocate to the West Coast. Also, T. Rowe Price taps a manager to be director of research for U.S. equities.

  7. T. Rowe Price Thrives Despite a Tumultuous 2013

    The firm remains on solid footing after some unexpected manager and analyst departures.

  8. T. Rowe Price Thrives Despite a Tumultuous 2013

    The firm remains on solid footing after some unexpected manager and analyst departures.

  9. What Investors Were Researching in May

    Investors continued their search for income in May, as the future of monetary policy came into sharp focus during the month.

  10. Fund Changes Bring New Analyst Ratings

    Morningstar's Russ Kinnel examines recent fund Analyst Rating upgrades and downgrades and offers guidelines for investors who own these funds.

123
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.